Navigation Links
Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
Date:11/1/2007

SAN DIEGO, Nov. 1 /PRNewswire/ -- Amira Pharmaceuticals, Inc. announced completion of the company's Phase 1 clinical trial of AM103, Amira's internally discovered oral drug candidate for the treatment of inflammatory diseases linked to the leukotriene pathway. Amira also announced the start of a Phase 1 trial for AM803, a second oral drug candidate that targets the same inflammatory response.

AM103 and AM803 are novel inhibitors of 5-lipoxygenase-activiting protein (FLAP) that have demonstrated potential to treat asthma and cardiovascular disease (CVD) by preventing the synthesis of leukotrienes (LT), which trigger inflammation. The recently completed AM103 trial was designed to assess the safety and tolerability of an escalating single dose of the compound and escalating multiple doses in healthy volunteers who received AM103 or placebo for up to 11 days. The trial also assessed the pharmacodynamic properties of AM103, specifically its ability to inhibit LT production.

Results from the Phase 1 trial show that AM103 is safe and well-tolerated at doses up to 1,000 mg per day with no evidence of significant side effects. The systemic exposure of AM103 increased linearly from 50 mg to 1,000 mg.

Pharmacodynamic data demonstrated a robust and statistically significant reduction of LTB4 and LTE4 in a dose-dependent manner. "The results from this trial meet and even exceed our expectations for safety, and provide pharmacodynamic evidence consistent with this mechanism of action," said Peppi Prasit, Amira's chief scientific officer. "The half-life of up to 10 hours also gives us the opportunity to evaluate once-daily dosing in a Phase 2 trial, which we expect to start in 2008."

"Based on this very favorable profile, the excellent tolerability and the high levels of exposure obtained with oral dosing in Phase 1 studies, we are moving forward to conduct a Phase 2 study with AM103 in asthmatic patients," said Bob Baltera, Amira's chief executive
'/>"/>

SOURCE Amira Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... as one of 20 finalists for America’s Favorite Veterinarian. The contest is put ... by a judging committee from 500 nominees. Nominees were evaluated on community involvement, ...
(Date:8/4/2015)... ... 04, 2015 , ... The Law Offices of Ben C. Martin , ... with Inferior Vena Cava Filters (“IVC Filters”). , As lead IVC filter lawyer for ... Filter clients under In re Cook Medical, Inc., IVC Filters Marketing, Sales Practices and ...
(Date:8/4/2015)... Louis, MO (PRWEB) , ... August 04, 2015 ... ... attorneys handling national talcum powder lawsuits filed against Johnson & Johnson report that ... Talcum powder lawyers provide regular news updates and cancer warning information ...
(Date:8/4/2015)... ... August 04, 2015 , ... Continuing ... in support of an interaction simulation session entitled "NOACS: What the Evidence Shows ... by Medical Learning Institute Inc. and EDUmotion US LLC. , This special activity ...
(Date:8/4/2015)... ... 2015 , ... Lightning Labels is pleased to announce the ... usher in a new standard of sticker and label-making for the company. , ... twin objectives of quality and quantity without compromising the signature lightning-fast speed we ...
Breaking Medicine News(10 mins):Health News:Dr. Gary Richter, Oakland Holistic Veterinarian, Among 20 Finalists for America’s Favorite Veterinarian 2Health News:Dr. Gary Richter, Oakland Holistic Veterinarian, Among 20 Finalists for America’s Favorite Veterinarian 3Health News:Law Offices of Ben C. Martin in Dallas Files New IVC Filter Complications Lawsuits and Pursues Settlements 2Health News:Law Offices of Ben C. Martin in Dallas Files New IVC Filter Complications Lawsuits and Pursues Settlements 3Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 2Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 3Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 4Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 2Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 3Health News:Lightning Labels Installs State-of-the-Art Digital Press 2Health News:Lightning Labels Installs State-of-the-Art Digital Press 3
... Medical University ... epidural prefrontal cortical stimulation , CHARLESTON, S.C., Oct. 13 ... with treatment-resistant depression. Bilateral epidural prefrontal cortical stimulation (EpCS) was ... in a small group of patients, according to lead researcher ...
... Package Continues to Provide Daily Requirement of Milk and ... The following was issued today by the Dairy Council ... available to WIC participants has garnered public attention, it ... continue to be strongly supported nutrient-rich options in this ...
... October marks Domestic Violence Awareness month and on October ... professionals across the country will reflect on over 800 ... restored by the American Academy of Cosmetic Dentistry Charitable ... (Photo: http://www.newscom.com/cgi-bin/prnh/20091013/DC91525 ) , ...
... invasive procedures (including the use of robotic assistance) for ... may shorten hospital stays and decrease respiratory and surgical ... of certain complications, including incontinence and erectile dysfunction, according ... JAMA , a theme issue on surgical care. ...
... 13, 2009 Early action, especially rapid rollout of vaccines, ... H1N1 influenza virus, according to a simulation model of a ... CMAJ ( Canadian Medical Association Journal ) ... that projects how many people will be infected under different ...
... finds better short-term results for endovascular repair than for ... A less-invasive method of abdominal aortic aneurysm (AAA) repair ... new U.S. study. , The interim findings are from ... and open surgical repair of AAA. The report included ...
Cached Medicine News:Health News:New Brain Stimulation Treatment May Offer Hope For Those With Treatment Resistant Depression 2Health News:New Brain Stimulation Treatment May Offer Hope For Those With Treatment Resistant Depression 3Health News:With All the Focus on What's New, Milk Remains Tried and True 2Health News:Over 800 Lives of Domestic Violence Survivors Restored by the American Academy of Cosmetic Dentistry Charitable Foundation's Give Back A Smile Program 2Health News:Minimally invasive radical prostatectomy shows advantages, but also certain complications 2Health News:H1N1 simulation modeling shows rapid vaccine rollout effective in reducing infection rates 2Health News:Study Compares Abdominal Aortic Aneurysm Repair Methods 2
(Date:8/3/2015)... -- ReportsnReports.com adds Global Medical Simulation ... as well as Global Medical Simulation Market 2015-2019 ... of its library. Complete 2015 report ... across 164 pages, talking about 7 major companies ... now available at http://www.reportsnreports.com/reports/407046-global-medical-simulation-industry-report-2015.html . ...
(Date:8/3/2015)... Aug. 3, 2015  Sage Analytics ( www.sageanalytics.com ), ... cannabis potency measurement systems, announced its sponsorship of the ... Fundraiser. A limited number of tickets are available for ... a great cause while enjoying an open bar, buffet ... the San Francisco Bay at sunset. With ...
(Date:8/3/2015)... Aug. 3, 2015   ConvergeHEALTH by ... Allergan plc is expanding its year-long ... Intermountain Healthcare to include women,s health.  ... analytics platform to generate real-world clinical insights in ... "We look forward to expanding our work with ...
Breaking Medicine Technology:Medical Simulation Market to see 14% CAGR to 2019 2Medical Simulation Market to see 14% CAGR to 2019 3Medical Simulation Market to see 14% CAGR to 2019 4Medical Simulation Market to see 14% CAGR to 2019 5Medical Simulation Market to see 14% CAGR to 2019 6Sage Analytics Sponsors California Cannabis Industry Association Bay Area Cruise FUNdraiser 2ConvergeHEALTH by Deloitte and Intermountain Healthcare Expand Real World Evidence Collaboration with Allergan to Focus on Women's Health 2ConvergeHEALTH by Deloitte and Intermountain Healthcare Expand Real World Evidence Collaboration with Allergan to Focus on Women's Health 3ConvergeHEALTH by Deloitte and Intermountain Healthcare Expand Real World Evidence Collaboration with Allergan to Focus on Women's Health 4
... Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced ... as Vice President of Quality.  In this newly created ... Machielse, Mr. Maines will be responsible for Quality, Validation ... Maines brings to the Company more than 25 years ...
... Reportlinker.com announces that a new market ... Global Eyeglasses Industry ... This report analyzes the worldwide markets for ... by the following Product Segments: Lenses, Frames ...
Cached Medicine Technology:Timothy J. Maines Joins Omthera Pharmaceuticals as Vice President of Quality 2Global Eyeglasses Industry 2Global Eyeglasses Industry 3Global Eyeglasses Industry 4Global Eyeglasses Industry 5Global Eyeglasses Industry 6Global Eyeglasses Industry 7Global Eyeglasses Industry 8Global Eyeglasses Industry 9Global Eyeglasses Industry 10Global Eyeglasses Industry 11Global Eyeglasses Industry 12Global Eyeglasses Industry 13
The Gizmo male external catheter is a latex catheter that uses a single-sided adhesive strip....
... Medical's line of Personal ... catheters you would choose ... product configurations - standard, ... hydro - are based ...
Active Cath is a latex, self-adhering, one piece catheter designed for extended wear. It combines a shortened latex sheath with a wide adhesive seal....
The Freedom Clear® LS Long Seal is a 100% latex-free, self-adhering, one piece catheter with an ultra-thin sheath for everyday wear. Its long seal provides added security....
Medicine Products: